Skip to content
Use case 138

Bedside Patient Monitors

A deployment concept for hospitals, monitor manufacturers, biomedical engineers and clinical safety teams.

Proposed deployment · Compatibility assessment required
Healthcare and Life Sciences

Why this environment matters

Modern bedside patient monitors depend on complex software, external data and remote administration. Here, the system collects and displays vital signs such as heart rate, oxygen saturation and blood pressure. If trust is misplaced, falsified readings, unavailable alarms or remote compromise can mislead clinicians during acute care. NØNOS could narrow the trusted computing base and give each function only the resources required for its defined job.

The security challenge

The threat model should assume that one component will eventually fail or be exploited. In this case, falsified readings, unavailable alarms or remote compromise can mislead clinicians during acute care. Healthcare systems process deeply sensitive data while supporting time-critical clinical decisions. Security must improve trust without delaying care or obscuring the human responsibility for treatment. The aim is to prevent that single failure from automatically gaining the keys, devices, records and network paths of the whole platform.

How the capsule model could help

A candidate NØNOS architecture would separate sensor drivers, alarm logic, network export and service tools, keeping clinical display available from a known-good image. The design would prioritise attested privileged sessions and patient-context capabilities, supported by signed clinical software and isolated medical file parsers. Each capsule would carry a declared policy for files, networks, devices and secrets, and unknown or altered software would not receive the same authority as an approved component.

Separate address spaces and capability checks can limit cross-process reach. They cannot stop harmful use of legitimate permissions, prove AI decisions correct or substitute for domain-specific safety controls.

Deployment requirements

Clinical deployment would require medical-device validation, patient-safety risk management, privacy review, human factors testing and integration with existing approved workflows. Security controls must never obstruct emergency care.

Current public-beta limitations, hardware support and application availability must be assessed before any pilot. Neither this use case nor an industry source establishes NONOS certification or a current customer deployment.

Who could buy or integrate it?

  • Patient-monitor manufacturers integrating bedside compute
  • Hospital groups procuring bedside monitoring systems
  • Medical technology integrators deploying monitoring networks

Industry examples: Philips, Nihon Kohden. Organisations shown illustrate the industry. No NONOS customer, partner or endorsement relationship is implied.

Market opportunity

Market benchmarks and device scenarios.

Published industry benchmark
US$54.3 billion

Patient monitoring devices

Global · 2025 · annual market estimate

Monitoring device categories across hospitals, ambulatory facilities and home care.

Modelled global devices
2M–30M

Candidate OS endpoints

Hypothetical planning range · 2025

Low confidence: planning assumptions. Hardware compatibility, procurement and adoption have not been validated.

Illustrative annual licensing
$10M–$1.5B

USD / year at full model coverage

Device scenario × assumed US$5–$50 per device / year.

Not a revenue forecast, announced price or measured serviceable market.

Device calculation

Hypothetical global planning range, 2025 scenario: assume 100,000–300,000 inpatient facilities and large monitored-care centers × 20–100 candidate OS endpoints per site/asset = 2,000,000–30,000,000 endpoints. Counting unit: bedside patient monitoring computers; individual sensor probes excluded. Site and asset counts, and devices per site, are planning assumptions. The installed base has not been measured. Coverage is limited to the defined equipped subset; includes all candidate endpoints within that assumed subset. Hardware eligibility, certification, adoption and achievable NØNOS share are unverified; overlaps other cases.

Patient Monitoring Devices Market Size Report, 2026-2033 ↗

Market context only; separate from device and site population estimates. Original monetary-market scope and geography are preserved in benchmark. This source does not establish the assumed worldwide site count or endpoint density.

How to interpret the figures

Adjacent or broader commercial market benchmark; not the NØNOS OS market, licensable-device count or revenue forecast.

Modelled candidate endpoints multiplied by an assumed annual USD price per endpoint. Pricing is a planning assumption, not a vendor quote. This illustrates the full scenario range, not revenue or total addressable market. It excludes adoption timing, procurement, certification, support costs, channel economics and achievable market share. Use cases can overlap, so their totals do not represent unique devices.

Research from 2026. Publisher estimates have not been independently audited.

Read the full methodology

Explore NONOS

Choose your
NONOS experience.

Discover the platform for your organisation or explore the software.

You can reopen this chooser from the footer at any time.